Literature DB >> 26338814

Pattern of extrapyramidal signs in Alzheimer's disease.

Giuseppe Tosto1,2, Sarah E Monsell3, Stephen E Hawes3,4, Richard Mayeux5,6,7,8.   

Abstract

Patients with Alzheimer's disease (AD) often develop extrapyramidal signs (EPS), which increase in frequency as the disease progresses. We aimed to investigate the patterns of presentation of EPS in AD and their correlation with clinical and neuropathological features. 4284 subjects diagnosed with AD from the National Alzheimer's Coordinating Center (NACC) database with at least one abnormal Unified Parkinson's Disease Rating Scale (UPDRS) assessment were included. Individuals were assigned to a discovery sample and a sensitivity analysis sample (moderate and mild dementia, respectively) and a subset of subjects provided neuropathological data (n = 284). Individuals from the Washington Heights and Inwood Columbia Aging Project (WHICAP) served as validation sample. Patterns of presentation of EPS were identified employing categorical principal component analysis (CATPCA). Six principal components were identified in both mild and moderate AD samples: (I) hand movements, alternating movements, finger tapping, leg agility ("limbs bradykinesia"); (II) posture, postural instability, arising from chair, gait and body bradykinesia/hypokinesia ("axial"); (III) limb rigidity ("rigidity"); (IV) postural tremor; (V) resting tremor; (VI) speech and facial expression. Similar results were obtained in the WHICAP cohort. Individuals with hallucinations, apathy, aberrant night behaviors and more severe dementia showed higher axial and limb bradykinesia scores. "Limb bradykinesia" component was associated with a neuropathological diagnosis of Lewy body disease and "axial" component with reduced AD-type pathology. Patterns of EPS in AD show distinct clinical and neuropathological correlates; they share a pattern of presentation similar to that seen in Parkinson's disease, suggesting common pathogenic mechanisms across neurodegenerative diseases.

Entities:  

Keywords:  Alzheimer’s disease; CATPCA; Extrapyramidal signs; Lewy bodies

Mesh:

Year:  2015        PMID: 26338814      PMCID: PMC4776751          DOI: 10.1007/s00415-015-7886-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Nonlinear principal components analysis with CATPCA: a tutorial.

Authors:  Mariëlle Linting; Anita van der Kooij
Journal:  J Pers Assess       Date:  2012

2.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.

Authors:  Florence Portet; Nikolaos Scarmeas; Stephanie Cosentino; Elisabeth P Helzner; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-09

3.  Interrater reliability of extrapyramidal signs in a group assessed for dementia.

Authors:  M Richards; K Marder; K Bell; G Dooneief; R Mayeux; Y Stern
Journal:  Arch Neurol       Date:  1991-11

4.  Nonlinear principal components analysis: introduction and application.

Authors:  Mariëlle Linting; Jacqueline J Meulman; Patrick J F Groenen; Anita J van der Koojj
Journal:  Psychol Methods       Date:  2007-09

5.  Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals.

Authors:  Joseph H Lee; Rong Cheng; Sandra Barral; Christiane Reitz; Martin Medrano; Rafael Lantigua; Ivonne Z Jiménez-Velazquez; Ekaterina Rogaeva; Peter H St George-Hyslop; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-11-08

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Motor signs predict poor outcomes in Alzheimer disease.

Authors:  N Scarmeas; M Albert; J Brandt; D Blacker; G Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; D Wegesin; K Marder; K Bell; L Honig; Y Stern
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

8.  The factor structure of the UPDRS as an index of disease progression in Parkinson's disease.

Authors:  Jonathan R Evans; Sarah L Mason; Caroline H Williams-Gray; Thomas Foltynie; Matthew Trotter; Roger A Barker
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

9.  Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.

Authors:  Martí Colom-Cadena; Ellen Gelpi; Sara Charif; Olivia Belbin; Rafael Blesa; Maria J Martí; Jordi Clarimón; Alberto Lleó
Journal:  J Neuropathol Exp Neurol       Date:  2013-12       Impact factor: 3.685

Review 10.  Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?

Authors:  Rick C Helmich; Mark Hallett; Günther Deuschl; Ivan Toni; Bastiaan R Bloem
Journal:  Brain       Date:  2012-03-01       Impact factor: 13.501

View more
  10 in total

Review 1.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

Review 2.  Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

3.  Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation?

Authors:  Osmar Vieira Ramires Junior; Tiago Marcon Dos Santos; Josiane Silva Silveira; Raíssa Leite-Aguiar; Robson Coutinho-Silva; Luiz Eduardo Baggio Savio; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2022-05-17       Impact factor: 5.590

4.  Discovery of Molecular Networks of Neuroprotection Conferred by Brahmi Extract in Aβ42-Induced Toxicity Model of Drosophila melanogaster Using a Quantitative Proteomic Approach.

Authors:  Sayali Chandrashekhar Deolankar; Mohd Altaf Najar; Poornima Ramesh; Anagha Kanichery; Avinash K Kudva; Shamprasad Varija Raghu; T S Keshava Prasad
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

5.  Early manifestation of gait alterations in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Anna Csiszar; Zoltan Ungvari; Stefano Tarantini; Adam Nyul-Toth; Jordan DelFavero; Peter Mukli; Amber Tarantini; Anna Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2021-06-23       Impact factor: 7.713

6.  Multiple step saccades in simply reactive saccades could serve as a complementary biomarker for the early diagnosis of Parkinson's disease.

Authors:  Wenbo Ma; Min Li; Junru Wu; Zhihao Zhang; Fangfang Jia; Mingsha Zhang; Hagai Bergman; Xuemei Li; Zhipei Ling; Xin Xu
Journal:  Front Aging Neurosci       Date:  2022-07-27       Impact factor: 5.702

Review 7.  Mechanisms of cognitive dysfunction in CKD.

Authors:  Davide Viggiano; Carsten A Wagner; Gianvito Martino; Maiken Nedergaard; Carmine Zoccali; Robert Unwin; Giovambattista Capasso
Journal:  Nat Rev Nephrol       Date:  2020-03-31       Impact factor: 28.314

8.  Evaluation of the primary care for chronic diseases in the high coverage context of the Family Health Strategy.

Authors:  Kelly Cristina Gomes Alves; Rafael Alves Guimarães; Marta Rovery de Souza; Otaliba Libânio de Morais Neto
Journal:  BMC Health Serv Res       Date:  2019-11-29       Impact factor: 2.655

9.  Performance of family health teams for tackling chronic diseases in a state of the Amazon.

Authors:  Kelly Cristina Gomes Alves; Rafael Alves Guimarães; Marta Rovery de Souza; Otaliba Libânio de Morais Neto
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

10.  Assessment of finger motor function that reflects the severity of cognitive function.

Authors:  Shota Suzumura; Yoshikiyo Kanada; Aiko Osawa; Junpei Sugioka; Natsumi Maeda; Taishi Nagahama; Kenta Shiramoto; Katsumi Kuno; Shiori Kizuka; Yuko Sano; Tomohiko Mizuguchi; Akihiko Kandori; Izumi Kondo
Journal:  Fujita Med J       Date:  2020-12-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.